Company / Operating Cash Flow per Share
Arcellx, Inc. Operating Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$3.87
FY2025
5-year range
-$121.51 / $4.71
FY2021-FY2025
Trend
-142.6%
vs FY2024
Sector context
#187 of 212
Health Care
What the data says
Arcellx, Inc.'s operating cash flow per share of $-3.87 is lower than 88% of companies in the Health Care sector (FY2025). Declined from $4.71 to $-3.87 over the past 2 years.
Based on SEC 10-K filings.
-3.87 in FY2025.
Declined from $4.71 to $-3.87 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 212This company -$3.87 Sector average -$14.72
▼
+73.7% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 142.6% year-over-year.
- Ranks #187 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.02 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.87 | -142.6% |
| FY2024 | -$1.60 | -133.9% |
| FY2023 | $4.71 | +272.3% |
| FY2022 | -$2.73 | +97.8% |
| FY2021 | -$121.51 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026